Overview

Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

Status:
Terminated
Trial end date:
2019-01-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the side effects and effectiveness of giving standard paclitaxel chemotherapy in doses based on actual body surface area in combination with standard dosed carboplatin chemotherapy for overweight women.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel